Lessons learned from extracorporeal membrane oxygenation use for COVID-19-Related myocarditis in China

Abstract

Get full access to this article

View all access options for this article.

References

Barhoum

Pineton de Chambrun

Dorgham

, et al. Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults. J Am Coll Cardiol 2022; 80(4): 299–312.

Okor

Bob-Manuel

Price

, et al. COVID-19 Myocarditis: An Emerging Clinical Conundrum. Curr Probl Cardiol 2022; 47(9): 101268.

Wang

Yang

Wang

, et al. Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score. Crit Care 2019; 23(1): 11.

Jentzer

van Diepen

Barsness

, et al. Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol 2019; 74(17): 2117–2128.

Tonna

Tan

Hryniewicz

, et al. Outcomes after extracorporeal life support for COVID-19 myocarditis: an analysis of the Extracorporeal Life Support Organization Registry. Crit Care 2022; 26(1): 235.

Hao

Jiang

, et al. Clinical outcome and risk factors for acute fulminant myocarditis supported by venoarterial extracorporeal membrane oxygenation: An analysis of nationwide CSECLS database in China. Int J Cardiol 2023; 371: 229–235.